MUNGO, ELEONORA

MUNGO, ELEONORA  

ONCOLOGIA  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.059 secondi).
Titolo Data di pubblicazione Autore(i) File
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer 2019 Salaroglio I.C.; Mungo E.; Gazzano E.; Kopecka J.; Riganti C.
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells. 2018 Loredana Bergandi, Eleonora Mungo, Rosa Morone, Ornella Bosco, Barbara Rolando, Sophie Doublier
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 2018 Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
Klebsiella pneumoniae: emergence of multi-drug-resistant strains in Northwest Italy. 2012 Leone I.; Mungo E.; Bisignano G.; Chirillo M.G.; Savoia D.
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 2016 Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 2020 Kopecka J, Gazzano E, Castella B, Salaroglio IC, Mungo E, Massaia M, Riganti C
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells 2018 Mungo Eleonora, Bergandi Loredana, Salaroglio iris Chiara, Doublier Sophie